# The Physiologic Effects of Intranasal Oxytocin on Sarcopenic Obesity

> **NCT03119610** · PHASE1,PHASE2 · COMPLETED · sponsor: **Sara Espinoza** · enrollment: 23 (actual)

## Conditions studied

- Obesity
- Sarcopenic Obesity
- Sarcopenia
- Aging
- Sedentary Lifestyle

## Interventions

- **DRUG:** Oxytocin nasal spray
- **DRUG:** Placebo nasal spray

## Key facts

- **NCT ID:** NCT03119610
- **Lead sponsor:** Sara Espinoza
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-22
- **Primary completion:** 2018-12-17
- **Final completion:** 2019-12-17
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2021-10-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03119610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03119610, "The Physiologic Effects of Intranasal Oxytocin on Sarcopenic Obesity". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03119610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*